GB0419159D0 - Organic compounds - Google Patents

Organic compounds

Info

Publication number
GB0419159D0
GB0419159D0 GBGB0419159.9A GB0419159A GB0419159D0 GB 0419159 D0 GB0419159 D0 GB 0419159D0 GB 0419159 A GB0419159 A GB 0419159A GB 0419159 D0 GB0419159 D0 GB 0419159D0
Authority
GB
United Kingdom
Prior art keywords
organic compounds
compounds
organic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB0419159.9A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novartis AG
Original Assignee
Novartis AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis AG filed Critical Novartis AG
Priority to GBGB0419159.9A priority Critical patent/GB0419159D0/en
Publication of GB0419159D0 publication Critical patent/GB0419159D0/en
Priority to PCT/EP2005/009253 priority patent/WO2006021456A1/en
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A61K31/553—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having at least one nitrogen and one oxygen as ring hetero atoms, e.g. loxapine, staurosporine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
GBGB0419159.9A 2004-08-27 2004-08-27 Organic compounds Ceased GB0419159D0 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
GBGB0419159.9A GB0419159D0 (en) 2004-08-27 2004-08-27 Organic compounds
PCT/EP2005/009253 WO2006021456A1 (en) 2004-08-27 2005-08-26 Combination comprising a staurosporine and a cyp3a4 inhibitor

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0419159.9A GB0419159D0 (en) 2004-08-27 2004-08-27 Organic compounds

Publications (1)

Publication Number Publication Date
GB0419159D0 true GB0419159D0 (en) 2004-09-29

Family

ID=33104744

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB0419159.9A Ceased GB0419159D0 (en) 2004-08-27 2004-08-27 Organic compounds

Country Status (2)

Country Link
GB (1) GB0419159D0 (en)
WO (1) WO2006021456A1 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8501792B2 (en) 2008-02-19 2013-08-06 David A. Potter Treating cancer with desthiazolyl ritonavir
CN102101866A (en) * 2010-11-04 2011-06-22 中国海洋大学 Halogenated derivatives of staurosporine, and preparation method thereof and use thereof
CN103169703B (en) * 2011-12-22 2014-10-08 清华大学深圳研究生院 New application of sertindole drug

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19744676A1 (en) * 1997-10-10 1999-04-15 Forschungszentrum Borstel Zent Combination product for cancer therapy
GB9903547D0 (en) * 1999-02-16 1999-04-07 Novartis Ag Organic compounds
IL161156A0 (en) * 2001-10-30 2004-08-31 Novartis Ag Staurosporine derivatives as inhibitors of flt3 receptor tyrosine kinase activity
US20040246627A1 (en) * 2003-06-06 2004-12-09 Durrum Thomas M. Disc drive pivot bearing assembly
TWI324604B (en) * 2003-06-18 2010-05-11 Novartis Ag New use of staurosporine derivatives
EP1653973A1 (en) * 2003-08-08 2006-05-10 Novartis AG Combinations comprising staurosporines
US20050159404A1 (en) * 2003-09-11 2005-07-21 Ming-Sing Si Organic compound
WO2005053704A1 (en) * 2003-12-01 2005-06-16 Novartis Ag Method for predicting drug responsiveness in myeloid neoplasms

Also Published As

Publication number Publication date
WO2006021456A1 (en) 2006-03-02

Similar Documents

Publication Publication Date Title
GB0410712D0 (en) Organic compounds
GB0409921D0 (en) Organic compounds
GB0403038D0 (en) Organic compounds
GB0407723D0 (en) Organic compounds
GB0401334D0 (en) Organic compounds
GB0405289D0 (en) Organic compounds
GB0402797D0 (en) Organic compounds
GB0404434D0 (en) Organic compounds
GB0408078D0 (en) Organic compounds
GB0400781D0 (en) Organic compounds
GB0425661D0 (en) Organic compounds
GB0403254D0 (en) Organic compounds
GB0403115D0 (en) Organic compounds
GB0406515D0 (en) Organic compounds
GB0409236D0 (en) Organic compounds
GB0405723D0 (en) Organic compounds
GB0419159D0 (en) Organic compounds
GB0406240D0 (en) Organic compounds
GB0407607D0 (en) Organic compounds
GB0405898D0 (en) Organic compounds
GB0405034D0 (en) Organic compounds
GB0407468D0 (en) Organic compounds
GB0404190D0 (en) Organic compounds
GB0406737D0 (en) Organic compounds
GB0403964D0 (en) Organic compounds

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)